Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Racemization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Novel patent CN105566319A details efficient moxifloxacin intermediate synthesis with high chiral purity and reduced costs for reliable supply chains.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN112851560A reveals a cost-effective racemization method for cis-D-hydroxyproline, offering high purity >99.5% and scalable production for pharma intermediates.
Patent CN115246815A details a novel nicotine preparation method recycling chiral resolution waste, offering high purity and reduced environmental impact for pharmaceutical manufacturers.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.